Use of granisetron in patients refractory to previous treatment with antiemetics

Anti-Cancer Drugs

Volumn 9, Issue 5, 1998, Pages 381-385

  Carmichael, James ^a   Keizer, H Jan ^b   Cupissol, Didier ^c   Milliez, Jacques ^d   Scheidel, Peter ^e   Schindler, Adolf E ^a  

^a NOTTINGHAM CITY HOSPITAL   (United Kingdom)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c CENTRE VAL D AURELLE   (France)

^d CENTRE HOSPITALIER INTERCOMMUNAL DE CRÉTEIL   (France)

^e Marienkrankenhaus   (Germany)

Author keywords

Antiemetic; Granisetron; Refractory; Repeat cycle

Indexed keywords

ALIZAPRIDE; CHLORPROMAZINE; CISPLATIN; CYTOSTATIC AGENT; DEXAMETHASONE; GRANISETRON; METOCLOPRAMIDE; ONDANSETRON;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CHILD; CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAUSEA; PRIORITY JOURNAL; SOMNOLENCE; VOMITING;

ADOLESCENT; ADULT; AGED; ANTIEMETICS; ANTINEOPLASTIC AGENTS; CHILD; CISPLATIN; CONSTIPATION; DRUG RESISTANCE; FEMALE; GRANISETRON; HEADACHE; HUMANS; MALE; MIDDLE AGED; NAUSEA; SEROTONIN ANTAGONISTS; TREATMENT OUTCOME; VOMITING;

EID: 0031844356     PISSN: 09594973     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001813-199806000-00002     Document Type: Article

References (15)

1. Laszlo J. Emesis as limiting toxicity in cancer chemotherapy. In: Laszlo J, ed. Antiemetics and cancer chemotherapy. Baltimore: Williams & Wilkins 1983: 1-5.
2. Roila F. Ondansetron plus dexamethasone compared to the 'standard' metoclopramide combination. Oncology 1993; 50: 163-7.
3. Italian Group for Antiemetic Research. Ondansetron+dexamethasone vs metoclopramide+dexamethasone+diphenhydramine in prevention of cisplatin-induced emesis. Lancet 1992; 340: 96-9.
4. Soukoup M. Clinical experience with intravenous granisetron. Anti-Cancer Drugs 1994; 5: 281-6.
5. Chevallier B on behalf of the Granisetron Study Group. Efficacy and safety of granisetron compared with high-dose metoclopramide plus dexamethasone in patients receiving high-dose cisplatin in a single-blind study. EurJ Cancer 1990; 26 (suppl 1): S33-6.
6. Marty M on behalf of the Granisetron Study Group. A comparison of granisetron as a single agent with conventional combination antiemetic therapies in the treatment of cytostatic-induced emesis. Eur J Cancer 1992; 28A (suppl 1): S12-6.
7. 3 receptor antagonists in the prophylaxis of acute vomiting induced by moderately emetogenic chemotherapy - a randomised study. Eur J Cancer 1993; 29A: 1669-72.
8. Noble A, Bremer K, Goedhals L, Cupissol D, Dilly SG on behalf of the Granisetron Study Group. A double-blind, randomised, crossover comparison of granisetron and ondansetron in 5-day fractionated chemotherapy: assessment of efficacy, safety and patient preference. Eur J Cancer 1994; 30A: 1083-8.
9. Roila F, Tonato M, Basurto C, et al. Protection from nausea and vomiting in cisplatin-treated patients: high-dose metoclopramide combined with methylprednisolone versus metoclopramide combined with dexamethasone and diphenhydramine: a study by the Italian oncology group for clinical research. J Clin Oncol 1989; 7: 1693-700.
10. Martin M, Diaz-Rubio E, Casado A, Dominguez S, Sastre J. Progressive loss of antiemetic efficacy during subsequent courses of chemotherapy. Eur J Cancer 1992; 28: 430-2.
11. Blijham GH on behalf of the Granisetron Study Group. Does granisetron remain effective over multiple cycles? Eur J Cancer 1992; 28A (suppl 1): S17-21.
12. Kamanabrou D on behalf of the Granisetron Study Group. Intravenous granisetron - establishing the optimal dose. Eur J Cancer 1992; 28A (suppl 1): S6-11.
13. Riviere A on behalf of the Granisetron Study Group. Dose finding study of granisetron in patients receiving high-dose cisplatin chemotherapy. Br J Cancer 1994; 69: 967-71.
14. Chevallier B on behalf of the Granisetron Study Group. The control of acute cisplatin-induced emesis - a comparative study of granisetron and a combination regimen of high-dose metoclopramide and dexamethasone. Br J Cancer 1993; 68: 176-80.
15. Cupissol D, Serrou B, Caubel M. The efficacy of granisetron as a prophylactic anti-emetic and intervention agent in high-dose cisplatin-induced emesis. Eur J Cancer 1990; 26 (suppl 1): 23-7.